Brief: Atomo Diagnostics And Access Bio Renegotiate Supply Agreements
05/10/2021 02:55
Oct 5 (Reuters) - Atomo Diagnostics Ltd AT1.AX :
* ATOMO AND ACCESS BIO RENEGOTIATE SUPPLY AGREEMENTS
* NEW AGREEMENT PROVIDES CO RIGHT TO PURCHASE UP TO 10
MILLION
COVID-19 RAPID ANTIGEN TESTS TILL CY22
* TO RECEIVE FROM ACCESS BIO ONE-OFF FEE CONSIDERED BY CO TO
BE
MATERIAL, REPLACING ANY PAYMENTS DUE UNDER EXISTING AGREEMENTS
Source https://bit.ly/3lb4BQN
Further company coverage: AT1.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Atomo Diagnostics
See all newsBrief: Atomo Diagnostics Signs Agreement With Innovation Scientific
Brief: Atomo Diagnostics Ltd Appoints Cheri Walker As Interim Ceo
Brief: Atomo Diagnostics Undertakes Capital Raising To Raise Up To A$4.0 Million
Australia's Atomo Diagnostics slumps on discounted capital raising
Brief: Atomo Diagnostics Seeks Trading Halt